Brexit’s impact on the European Medicines Agency and notice to Marketing Authorisation Holders
Following the UK’s decision to withdraw from the European Union, the European Medicines Agency(EMA) has been considering the implications for its location and operations. As no member state has left the EU before, there is no precedent for the situation the EMA finds itself in. What is clear though is that the EMA, will continue […]